Supernus Pharmaceuticals | SUPN - Ingresos Por Ventas





Ventas Cambio Fecha
Abbott USD 11.46B 90M 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Aurora Cannabis CAD 90.37M 7.65M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Novo Nordisk DKK 79.14B 4.16B 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09